Samsung’s Galaxy Watch 7 launched without a blood sugar sensor

Samsung’s Galaxy Watch 7 does not measure blood sugar. The watch went on sale in July 2024, and Samsung’s official launch announcement for the Galaxy Watch7 lists sleep, heart, and body measurements, but no blood glucose reading. A report published a few months before the launch had said the watch would add a blood sugar sensor. That feature did not arrive.

Blood glucose tracking matters for people with diabetes, who need to know their blood sugar to adjust food, activity, and medicines such as insulin. Today, they do this with finger-prick tests or with a continuous glucose monitor (CGM), a small sensor that sits partly under the skin. A watch that could read blood sugar through the skin, with no needle, would make this much easier. No such watch has been authorized by the US regulator.

What the Galaxy Watch 7 blood glucose rumor said

Before the launch, the South Korean business outlet Pulse reported that the industry expected blood sugar monitoring to arrive as a new feature of the Galaxy Watch 7. The French tech site Les Numériques relayed the report, and the first version of this Gromeus article was based on it. According to Les Numériques, Pulse described a meeting in Seoul between Hon Pak, who leads Samsung’s digital health work, and the advisory board of the Samsung Health platform, where diabetes and blood sugar monitoring were among the topics.

The same report claimed that Samsung could sell the watch as an ordinary electronic device instead of a medical device, to avoid long regulatory reviews. The report rested on industry expectations, and Les Numériques quotes no Samsung statement. Samsung did not announce a blood sugar feature before or at the launch.

What Samsung actually launched in the Galaxy Watch 7

Samsung presented the Galaxy Watch7 and the Galaxy Watch Ultra at its Galaxy Unpacked event in France on 10 July 2024, according to the release. The release gives 10 July for pre-orders in select markets and 24 July for general availability. The Galaxy Watch7 comes in two sizes, 40 mm and 44 mm, and runs on a new Exynos W1000 chip built on a 3 nm process, the release says.

The main medical feature is a Sleep Apnea feature that Samsung says received De Novo authorization from the FDA. De Novo is the FDA route for new kinds of low- to moderate-risk devices. Sleep apnea means repeated pauses in breathing during sleep. It also strains the heart: a Gromeus article explains how sleep apnea disrupts the link between sleep stages and heart rate. The release adds that the feature needs at least two days of sleep data within a span of ten days and is available in select countries only.

The watch also offers heart rate alerts, an irregular heart rhythm notification for signs of atrial fibrillation (a common heart rhythm problem), an electrocardiogram (ECG), and blood pressure readings. According to the release, blood pressure readings work in select markets and require calibration with a standard cuff every four weeks. These measurements rely on Samsung’s BioActive Sensor, which combines an optical sensor (light shone into the skin), an electrical heart signal sensor, and a body composition sensor.

The AGEs Index is the closest feature to blood sugar

The only new feature linked to sugar is the AGEs Index. AGEs, or advanced glycation end products, are compounds that form when sugars attach to proteins or fats in the body. Samsung says that AGEs are strongly influenced by diet and lifestyle and give an indication of metabolic health. According to the release, the Galaxy Watch7 estimates them with its light sensors.

The AGEs Index does not give a blood sugar level. The company presents it for fitness and wellness only and says it is not meant to diagnose or treat any condition. The release lists every sensor in the watch: none of them is a glucose sensor.

The FDA warns against watches that claim to measure blood sugar

In February 2024, the US Food and Drug Administration issued a safety warning against smartwatches and smart rings that claim to measure blood glucose without piercing the skin. The agency told people not to buy or use them, whatever the brand. According to the agency, it has not authorized, cleared, or approved any smartwatch or smart ring that measures blood glucose on its own.

The risk is concrete. A wrong reading can lead a person with diabetes to take the wrong dose of insulin or of another drug that lowers blood sugar. The FDA says that too much of these drugs can cause dangerously low blood sugar, with confusion, coma, or death possible within hours.

The warning does not apply to smartwatch apps that display readings from an FDA-authorized device that pierces the skin, such as a CGM. Anyone whose treatment depends on glucose readings should use an authorized device and discuss the choice with their doctor. Check these points against the sources below before choosing a device.

Where Samsung’s needle-free glucose sensor stands

Update (2025): in an editorial on its newsroom, Samsung’s head of digital health, Dr. Hon Pak, wrote that blood glucose is a big area of focus for the company. The editorial, dated 24 January 2025, says Samsung has been working on a sensor algorithm that predicts early signs of diabetes, on non-invasive blood glucose monitoring technology, and on nutrition coaching linked to CGMs.

The same editorial gives no launch date, no product, and no accuracy data for the needle-free sensor. Reading sugar through the skin with light is hard, because optical signals change with skin, movement, and how the device sits on the body. A separate Gromeus article looks at how wearable trackers try to overcome these accuracy limits.

For people who want steadier blood sugar without any device, simple habits already help: a short walk after eating helps prevent blood sugar spikes.

Sources and related information

Samsung – Samsung’s Expanded Wearables Portfolio Unlocks Intelligent Health Experiences for All – 2024

Samsung’s official release of 10 July 2024 lists the Galaxy Watch7 health features and sensors, including the Sleep Apnea feature, the AGEs Index, and the BioActive Sensor, with no blood glucose measurement. It also gives the sizes, chip, and availability dates cited above.

FDA – Do Not Use Smartwatches or Smart Rings to Measure Blood Glucose Levels – 2024

The US regulator’s safety communication of 21 February 2024 warns against wearables that claim needle-free glucose readings, states that none is authorized, and explains the risk of wrong insulin doses. It excludes apps that display data from authorized skin-piercing devices such as CGMs.

Samsung – Harnessing the Power of AI, editorial by Hon Pak – 2025

In this editorial, Samsung’s head of digital health describes the non-invasive glucose work and the diabetes prediction algorithm, without a launch date or product.

Les Numériques – Galaxy Watch 7 : Samsung introduirait un capteur de glycémie – 2024

This French article relays the Pulse report on a Galaxy Watch 7 glucose sensor, the rumor on which the first version of this article was based. The feature did not ship.

Leave a Reply

Your email address will not be published. Required fields are marked *